Addison Advisors’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 879 |
|
|
2025
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 839 |
|
|
2024
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 838 |
|
|
2024
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 834 |
|
|
2024
Q2 | $3 | Buy |
+1
| New | +$3 | ﹤0.01% | 773 |
|
|
2024
Q1 | – | Hold |
0
| – | -$1 | – | 697 |
|
|
2023
Q4 | – | Hold |
0
| – | -$2 | – | 705 |
|
|
2023
Q3 | – | Hold |
0
| – | -$4 | – | 680 |
|
|
2023
Q2 | – | Hold |
0
| – | -$7 | – | 629 |
|
|
2023
Q1 | – | Hold |
0
| – | -$8 | – | 626 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 784 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 739 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 734 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 761 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 699 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 453 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 400 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 379 |
|